Nasr S Z, Schaffert D
University of Michigan Medical Center, Department of Pediatrics, Ann Arbor 48109-0718, USA.
Pediatr Pulmonol. 1995 Jun;19(6):396-7. doi: 10.1002/ppul.1950190615.
A newly diagnosed 5-month-old infant with cystic fibrosis (CF) developed signs and symptoms of increased intracranial pressure (ICP) within days of starting pancreatic enzyme replacement therapy. Symptoms promptly resolved on two occasions after stopping enzyme replacement. At 10 months of age, enzyme replacement was well tolerated.
一名新诊断为囊性纤维化（CF）的5个月大婴儿在开始胰腺酶替代治疗数天内出现颅内压（ICP）升高的体征和症状。在停止酶替代治疗后，症状两次迅速缓解。在10个月大时，酶替代治疗耐受性良好。
